Halberd Corporation (HALB)
OTCMKTS · Delayed Price · Currency is USD
0.0009
0.00 (0.00%)
At close: Jul 29, 2026
Halberd Market Cap
Halberd has a market cap or net worth of $672.57 thousand as of July 29, 2026. Its market cap has decreased by -59.75% in one year.
Market Cap
672.57K
Enterprise Value
n/a
Revenue
6.94K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since June 25, 2009, Halberd's market cap has decreased from 2.61M to 672.57K, a decrease of -74.19%. That is a compound annual growth rate of -7.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 672.57K | -36.61% |
| Dec 31, 2025 | 1.06M | -58.29% |
| Dec 31, 2024 | 2.54M | -11.40% |
| Dec 29, 2023 | 2.87M | -4.05% |
| Dec 30, 2022 | 2.99M | -62.35% |
| Dec 31, 2021 | 7.95M | -4.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evofem Biosciences | 1.09M |
| Nymox Pharmaceutical | 1.06M |
| ZyVersa Therapeutics | 939.13K |
| Lyra Therapeutics | 922.94K |
| Avenue Therapeutics | 908.19K |
| Emmaus Life Sciences | 822.19K |
| Nextel Medical | 815.87K |
| Agentix | 801.34K |